Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Breast Cancer / Mammacarcinoma & ST6Gal 1 Sialyltransferase (ST6Gal-I)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

High expression levels of ST3 beta-galactoside alfa-2,3-sialyltransferase 3 (ST3GAL3) and ST6Gal 1 Sialyltransferase (ST6Gal-I) in human Breast Cancer / Mammacarcinoma are linked to poor prognosis markers. Specifically, elevated ST6Gal-I expression is associated with a histoprognostic grade III classification. Furthermore, there is a negative correlation between ST6Gal-I expression and the expression of progesterone receptors.
Recchi et al. 1998

…

References (Sources)

Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer
Recchi et al. 1998

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Breast Cancer / Mammacarcinoma & ST6Gal 1 Sialyltransferase (ST6Gal-I)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat